High-grade uterine corpus-confined endometrial cancer with lymphadenectomy: does adjuvant therapy improve survival?
İsmet Çiğdem KılıçCaner ÇakırDilek YükselYasin DurmuşNurettin BoranGünsu Kimyon CömertMustafa Alper KaralökGökhan BoyrazAhmet Taner TuranPublished in: Turkish journal of obstetrics and gynecology (2019)
Performing adjuvant therapy and therapy modality does not improve oncologic outcomes in intermediate and high-risk patients. However, radiotherapy reduced the risk of local recurrence by more than 50%. Vaginal brachytherapy was efficient as external beam radiotherapy. Therefore, vaginal brachytherapy should be used for these patients in order to reduce loco-regional recurrence even if it is not reported to be effective on disease-free survival.
Keyphrases
- free survival
- end stage renal disease
- endometrial cancer
- radiation therapy
- early stage
- high grade
- chronic kidney disease
- ejection fraction
- locally advanced
- prognostic factors
- peritoneal dialysis
- prostate cancer
- type diabetes
- stem cells
- rectal cancer
- patient reported outcomes
- squamous cell carcinoma
- lymph node
- adipose tissue
- skeletal muscle
- low grade
- insulin resistance
- neoadjuvant chemotherapy